Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis

Journal of Hepatology

Volumn 56, Issue 6, 2012, Pages 1239-1246

  Penna, Amalia ^a   Laccabue, Diletta ^a   Libri, Irene ^a   Giuberti, Tiziana ^a   Schivazappa, Simona ^a   Alfieri, Arianna ^a   Mori, Cristina ^a   Canetti, Diana ^a   Lampertico, Pietro ^b   Viganò, Mauro ^b   Colombo, Massimo ^b   Loggi, Elisabetta ^c   Missale, Gabriele ^a   Ferrari, Carlo ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Adaptive immunity; Antiviral therapy; Cytokines; PD 1

Indexed keywords

GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; PEGINTERFERON ALPHA2A; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOLOGICAL PARAMETERS; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TH1 CELL; TREATMENT RESPONSE;

EID: 84861184620     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.12.032     Document Type: Article

References (34)

1. A.S. Lok, and B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 1 36
2. A. Bertoletti, and C. Ferrari Kinetics of the immune response during HBV and HCV infection Hepatology 38 2003 4 13 (Pubitemid 36775788)
3. B. Rehermann, and M. Nascimbeni Immunology of hepatitis B virus and hepatitis C virus infection Nat Rev Immunol 5 2005 215 229 (Pubitemid 40364823)
4. E.C. Borden, G.C. Sen, and G. Uze Interferons at age 50: past, current and future impact on biomedicine Nat Rev 6 2007 975 990 (Pubitemid 350201788)
5. J.N. Stoop, R.G. van der Molen, and E.J. Kuipers Inhibition of viral replication reduces regulatory T-cells and enhances the antiviral immune response in chronic hepatitis B Virology 361 2007 141 148 (Pubitemid 46551232)
6. H. Cooksley, S. Chokshi, and Y. Maayan Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity Antimicrob Agents Chemother 52 2008 312 320
7. D. Sprengers, J.N. Stoop, and R.S. Binda Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-α therapy for chronic hepatitis B Antivir Ther 12 2007 1087 1096 (Pubitemid 350114989)
8. P. Carotenuto, A. Artsen, and H.G. Niesters In vitro use of autologous dendritic cells improves detection of T-cell responses to hepatitis B virus (HBV) antigens J Med Virol 81 2009 332 339
9. M.A. Rico, J.A. Quiroga, and D. Subirà Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon α Hepatology 33 2001 295 300 (Pubitemid 32016913)
10. I. Carey, L. D'Antiga, and S. Bansal Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy J Virol 85 2011 2416 2428
11. R. Moucari, V. Mackiewicz, and O. Lada Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon α-2a in HBeAg-negative patients Hepatology 49 2009 1151 1157
12. M.R. Brunetto, F. Moriconi, and F. Bonino Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon α-2a in HBeAg-negative chronic hepatitis B Hepatology 49 2009 1141 1150
13. C. Boni, P. Fisicaro, and C. Valdatta Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection J Virol 81 2007 1246 1254
14. M.K. Maini, C. Boni, and C.K. Lee The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection J Exp Med 191 2000 1269 1280 (Pubitemid 30227116)
15. G.J.M. Webster, S. Reignat, and D. Brown Longitudinal analysis of CD8+ T-cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy J Virol 78 2004 5707 5719 (Pubitemid 38661658)
16. E.J. Wherry, J.N. Blattman, and K. Murali-Krishna Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment J Virol 77 2003 4911 4927 (Pubitemid 36402840)
17. E.J. Wherry, S.J. Ha, and S.M. Kaech Molecular signature of CD8+ T-cell exhaustion during chronic viral infection Immunity 27 2007 670 684 (Pubitemid 47615511)
18. M.E. Keir, M.J. Butte, and G.J. Freeman PD-1 and its ligands in tolerance and immunity Annu Rev Immunol 26 2008 677 704 (Pubitemid 351600389)
19. C.L. Day, D.E. Kaufmann, and P. Kiepiela PD-1 expression on HIV-specific T-cells is associated with T-cell exhaustion and disease progression Nature 443 2006 350 354 (Pubitemid 44435155)
20. P. Fisicaro, C. Valdatta, and M. Massari Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B Gastroenterology 138 2010 682 693
21. S. Urbani, B. Amadei, and D. Tola PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion J Virol 80 2006 11398 11403 (Pubitemid 44706581)
22. H. Radziewicz, C.C. Ibegbu, and M.L. Fernandez Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression J Virol 81 2006 2453 2545
23. L. Golden-Mason, B. Palmer, and J. Klarquist Upregulation of PD-1 expression on circulating and intrahepatic HCV-specific CD8+T-cells associated with reversible immune dysfunction J Virol 81 2007 9249 9258 (Pubitemid 47311467)
24. A. Penna, M. Pilli, and A. Zerbini Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection Hepatology 45 2007 588 601 (Pubitemid 46450610)
25. N. Nakamoto, D.E. Kaplan, and J. Coleclough Functional restoration of HCV-specific CD8 T-cells by PD1 blockade is defined by PD1 expression and compartmentalization Gastroenterology 134 2008 1927 1937
26. D.G. Brooks, M.J. Trifilo, and K.H. Edelmann Interleukin-10 determines viral clearance or persistence in vivo Nat Med 12 2006 1301 1309 (Pubitemid 44706933)
27. M. Ejrnaes, C.M. Filippi, and M.M. Martinic Resolution of a chronic viral infection after interleukin-10 receptor blockade J Exp Med 203 2006 2461 2472 (Pubitemid 44664616)
28. D. Accapezzato, V. Francavilla, and M. Paroli Hepatic expansion of a virus-specific regulatory CD8(+) T-cell population in chronic hepatitis C virus infection J Clin Invest 113 2004 963 972 (Pubitemid 38544117)
29. N. Alatrakchi, C.S. Graham, and H.J. van der Vliet Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses J Virol 81 2007 5882 5892 (Pubitemid 46847025)
30. E.M. Shevach From vanilla to 28 flavors: multiple varieties of T regulatory cells Immunity 25 2 2006 195 201 (Pubitemid 44224153)
31. J. Wherry, and R. Ahmed Memory CD8 T-cell differentiation during viral infection J Virol 78 2004 5535 5545 (Pubitemid 38661640)
32. H. Shin, and E.J. Wherry CD8 T-cell dysfunction during chronic viral infection Curr Opin Immunol 19 2007 408 415 (Pubitemid 47284857)
33. E.J. Wherry, J.N. Blattman, and R. Ahmed Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination J Virol 79 2005 8960 8968 (Pubitemid 40934807)
34. European Association For The Study Of The Liver EASL clinical practice guidelines: management of chronic hepatitis B J Hepatolog 50 2009 227 242